arrow
Return

Proton therapy for skull-base chondrosarcoma, a single-institution outcomes study

delete2019-03-02
delete39
PRE
AI
A
Adam L. Holtzman *
R
Ronny L. Rotondo
M
Michael S. Rutenberg
D
Daniel J. Indelicato
C
Catherine E. Mercado
D
Dinesh Rao
D
Daryoush Tavanaiepour
C
Christopher G. Morris
D
Debbie Louis
S
Stella Flampouri
W
William M. Mendenhall
DOI:10.1007/s11060-019-03129-8delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
BackgroundWe sought to evaluate the effectiveness of definitive or adjuvant external-beam proton therapy on local control and survival in patients with skull-base chondrosarcoma.MethodsWe reviewed the medical records of 43 patients with a median age of 49years (range, 23-80years) treated with double-scattered 3D conformal proton therapy for skull-base chondrosarcomas between January 2007 and February 2016. Proton therapy-related toxicities were scored using CTCAE v4.0.ResultsThe median radiotherapy dose was 73.8Gy(RBE) (range, 64.5-74.4 Gy[RBE]). Thirty-six (84%) and 7 (16%) patients underwent surgical resection or biopsy alone. Tumor grade distribution included: grade 1, 19 (44%) patients; grade 2, 22 (51%); and grade 3, 2 (5%). Forty patients had gross disease at the time of radiotherapy and 7 patients were treated for locally recurrent disease following surgery. The median follow-up was 3.7years (range, 0.7-10.1years). There were no acute grade 3 toxicities related to RT. At 4years following RT, actuarial rates of overall survival, cause-specific survival, local control, and RT-related grade 3 toxicity-free survival were 95%, 100%, 89%, and 95%.ConclusionHigh-dose, double-scattered 3D conformal proton therapy alone or following surgical resection for skull-base chondrosarcoma is an effective treatment with a high rate of local control with no acute grade 3 radiation-related toxicity. Further follow-up of this cohort is necessary to better characterize long-term disease control and late toxicities.
Keywords:
Radiation oncology
Proton therapy
Skull-based tumors
Chondrosarcomas
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

J
Journal of Neuro-Oncology
IF:
3.1
Papers:
8.1K
Citations:
1.5W

Organization

U
University of Florida
Scholars:
4.0W
Papers: 3.1W
Citations: 6.6W
State University System of Florida cover
State University System of Florida
Scholars:
12.6W
Papers: 10.8W
Citations: 130